Uncategorized
The legal landscape surrounding the Narcotic Drugs and Psychotropic Substances (NDPS) Act is undergoing a seismic shift in 2026. For entities operating in high-stakes sectors, such as Pharmaceutical Manufacturing Companies, Vaccine Storage & Biotech Companies, Hospitals, and Cold Chain Logistics, understanding these changes isn’t just a matter of legal compliance; it is a matter of
February 17, 2026
No Comments
